Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
While 25 compounds have been formally licensed for the treatment of HIV infection (AIDS), only seven licensed products are currently available for the treatment of chronic hepatitis B virus (HBV) infection: interferon-α, pegylated interferon-α, lamivudine, adefovir (dipivoxil), entecavir, telbivudin...
Main Authors: | Erik De Clercq, Geoffrey Férir, Suzanne Kaptein, Johan Neyts |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/2/6/1279/ |
Similar Items
-
HBV genotypes and antiviral therapy of hepatitis B
by: I.A. Zaitsev, et al.
Published: (2019-09-01) -
Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment
by: Zhang Dake, et al.
Published: (2012-12-01) -
Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes
by: Francisco Campello do Amaral Mello, et al.
Published: (2012-05-01) -
Antiviral therapy in chronic hepatitis C virus infection
by: Irina Russu
Published: (2019-09-01) -
Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday
by: Guangdi Li, et al.
Published: (2021-02-01)